Akpro

   
Google
 
Web NewDrugInformation.com

Akpro


Drug - Akpro
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dipivefrin Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - 0.1%
The potency of the active ingredient(s), Dipivefrin Hydrochloride. May repeat for multiple part products.

Applicant - AKORN
The firm name holding legal responsibility for Akpro. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074382
The FDA assigned number to Akpro. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Akpro. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Sep 29, 1995
The date Akpro was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Akpro. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Akpro is in. Format is RX, OTC, DISCN.

Applicant Full Name - Akorn Inc
The full name of the firm holding legal responsibility for the new application of Akpro.

Akpro